EPIICAL - THE HIV CLINICAL & EXPERIMENTAL PLATFORM

2019/12/10
Today we celebrate Human Rights Day. Percentage of HIV-infected children receiving antiretroviral therapy is still very low in low […]
read more
2019/12/05
Earth study enrols 150 patients
read more
2019/12/01
By working together we are doing what it takes to be a game changer in HIV remission science
read more

Human Immunodeficiency Virus (HIV) – Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children
2018/09/04
Background. Assays to estimate human immunodeficiency virus (HIV) reservoir size require large amounts of blood, which represents a drawback especially […]
read more
Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children
2018/06/26
Future strategies aiming to achieve HIV-1 remission are likely to target individuals with small reservoir size. We retrospectively investigated factors associated with HIV-1 DNA levels in European, perinatally HIV-infected children starting ART <6 months of age.
read more
Report from the First EPIICAL General Assembly meeting, 9–11 November 2017, Rome, Italy
2018/01/22
The first EPIICAL General Assembly meeting was held in an atmosphere of growing optimism. Many novel and exciting proposals for HIV research studies were […]
read more
The EPIICAL Project: an Emerging Global Collaboration to Investigate Immunotherapeutic Strategies in HIV-Infected Children
2016/02/16
The EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies) project arises from the firm belief […]
read more

By working together we are doing what it takes to be a game changer in HIV remission science